Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +48.81%
#3 Galxe Galxe +41.61%
#4 Infinity Ground Infinity Ground +30.19%
#5 Audiera Audiera +29.99%
#6 Fetch.ai Fetch.ai +26.67%
#7 Derive Derive +25.50%
#8 Wiki Cat Wiki Cat +25.33%
#9 Aria.AI Aria.AI +20.16%
#10 Fuzzybear Fuzzybear +18.58%
Coin of the day
Velas Velas
設定
言語
日本
通貨
USD
テーマ
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
株式のランク #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
株価
$38.41
時価総額
$170.67B
変化（1日）
1.17%
変化（1年）
-49.92%
国
DK
取引 Novo Nordisk A/S (NVO)

カテゴリー

Healthcare
時価総額
収益
もっと
利益
価格履歴
P/E比率
P/S比率
P/B比率
営業利益率
EPS
株式分割
配当金
配当利回り
発行済株式数
Novo Nordisk A/S（NVO）の株式分割履歴
Novo Nordisk A/S株（シンボル：NVO）は合計で3回の株式分割を実施しました。
最新の株式分割はSep 13, 2023に行われました。
Jan 25, 2008より前に購入されたNVO株は、現在20NVO株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2023-09-13 2:1 x2 x20
2014-01-02 5:1 x5 x10
2008-01-25 2:1 x2 x2
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 0 -
US
UCB SA UCB SA
UCB SA
UCB.BR
 0 -
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL